Salus Telehealth, Inc. – a market leader within the telehealth industry – is continuing an exciting transition following its recent merger with VideoMedicine, the world’s first mobile, free-market doctor network.
This week, the company announced its new seven-member board of directors as it strives to offer a true end-to-end telemedicine solution that will reduce the overall cost of healthcare as well as have a significant role in improving health outcomes for patients.
The group is an incredibly impressive one, with each member offering a wealth of experience and an extensive list of accomplishments. We don’t have enough room here to list the full resumes for these gifted individuals, but you can find brief introductions below.
Charles Butler, M.D. and creator of VideoMedicine, was elected chairman of the board. Dr. Butler received his Doctor of Medicine Degree from the New York University (NYU) School of Medicine, and is board certified by the American Board of Internal Medicine.
Bernard A. Harris, Jr., M.D., M.B.A., F.A.C.P., was elected vice chairman of the board. Dr. Harris is currently CEO and managing partner of Versalius Ventures, Inc., a venture capital firm that invests in early to mid-stage healthcare technologies and companies. Selected by NASA in January 1990, Dr. Harris became an astronaut in July 1991. He is qualified for assignment as a mission specialist on future Space Shuttle flight crews.
Paula Guy, President and CEO of Salus Telehealth, Inc., was also elected to the board as a founding member. Ms. Guy was instrumental in building the successful nonprofit company Global Partnership for Telehealth and has over 16 years of leadership experience building national and international telemedicine networks.
Board member Frederick Feit, M.D is director of the Fellowship Training Program in Interventional Cardiology and Associate Professor of Medicine at the NYU Langone School of Medicine. He is recognized internationally for his scientific contributions, technical expertise and pioneering research.
Brent Furse was also elected to the board. He currently serves as the Global Chief Commercial Officer and President of U.S. at Cardioentis AG. Mr. Furse has more than 25 years of healthcare commercial leadership experience, with 18 years in the acute care hospital medicine market.
Board member David Flannery, M.D. is the Medical Director at the American College of Medical Genetics and Genomics in Bethesda, Md. Prior to this role, Dr. Flannery served as a M.D. Clinical Geneticist at the Medical College of Georgia Health Sciences University.
Rene LaVigne, President and CEO of Iron Bow, was elected to the board as well. He brings more than 25 years of experience to the Salus Telehealth, Inc., board in sales, marketing, operations, financing and accounting in the information technology and financial industries.